K Pertiwi1, D E Kok2, A J Wanders3, J de Goede2, P L Zock3, J M Geleijnse2. 1. Division of Human Nutrition and Health, Wageningen University, the Netherlands. Electronic address: kamalita.pertiwi@wur.nl. 2. Division of Human Nutrition and Health, Wageningen University, the Netherlands. 3. Unilever R&D, Vlaardingen, the Netherlands.
Abstract
BACKGROUND AND AIMS: Population-based studies often use plasma fatty acids (FAs) as objective indicators of FA intake, especially for n-3 FA and linoleic acid (LA). The relation between dietary and circulating FA in cardiometabolic patients is largely unknown. We examined whether dietary n-3 FA and LA were reflected in plasma lipid pools in post-myocardial infarction (MI) patients. METHODS AND RESULTS: Patients in Alpha Omega Cohort filled out a 203-item food-frequency questionnaire from which eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and LA intake were calculated. Circulating individual FA (% total FA) were assessed in cholesteryl esters (CE; n = 4066), phospholipids (PL; n = 838), and additionally in total plasma for DHA and LA (n = 739). Spearman correlation coefficients (rs) were calculated for dietary vs. circulating FA. Circulating FA were also compared across dietary FA quintiles, overall and in subgroups by sex, obesity, diabetes, statin use, and high alcohol intake. Patients were on average 69 years old and 79% was male. Moderate correlations between dietary and circulating levels were observed for EPA (rs∼0.4 in CE and PL) and DHA (rs ∼0.5 in CE and PL, ∼0.4 in total plasma), but not for ALA (rs ∼0.0). Weak correlations were observed for LA (rs 0.1 to 0.2). Plasma LA was significantly lower in statin users and in patients with a high alcohol intake. CONCLUSIONS: In post-MI patients, dietary EPA and DHA were well reflected in circulating levels. This was not the case for LA, which may partly be influenced by alcohol use and statins.
BACKGROUND AND AIMS: Population-based studies often use plasma fatty acids (FAs) as objective indicators of FA intake, especially for n-3 FA and linoleic acid (LA). The relation between dietary and circulating FA in cardiometabolic patients is largely unknown. We examined whether dietary n-3 FA and LA were reflected in plasma lipid pools in post-myocardial infarction (MI) patients. METHODS AND RESULTS:Patients in Alpha Omega Cohort filled out a 203-item food-frequency questionnaire from which eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), alpha-linolenic acid (ALA), and LA intake were calculated. Circulating individual FA (% total FA) were assessed in cholesteryl esters (CE; n = 4066), phospholipids (PL; n = 838), and additionally in total plasma for DHA and LA (n = 739). Spearman correlation coefficients (rs) were calculated for dietary vs. circulating FA. Circulating FA were also compared across dietary FA quintiles, overall and in subgroups by sex, obesity, diabetes, statin use, and high alcohol intake. Patients were on average 69 years old and 79% was male. Moderate correlations between dietary and circulating levels were observed for EPA (rs∼0.4 in CE and PL) and DHA (rs ∼0.5 in CE and PL, ∼0.4 in total plasma), but not for ALA (rs ∼0.0). Weak correlations were observed for LA (rs 0.1 to 0.2). Plasma LA was significantly lower in statin users and in patients with a high alcohol intake. CONCLUSIONS: In post-MI patients, dietary EPA and DHA were well reflected in circulating levels. This was not the case for LA, which may partly be influenced by alcohol use and statins.
Authors: Pasi Soininen; Antti J Kangas; Peter Würtz; Taru Tukiainen; Tuulia Tynkkynen; Reino Laatikainen; Marjo-Riitta Järvelin; Mika Kähönen; Terho Lehtimäki; Jorma Viikari; Olli T Raitakari; Markku J Savolainen; Mika Ala-Korpela Journal: Analyst Date: 2009-07-30 Impact factor: 4.616
Authors: Allison M Hodge; Julie A Simpson; Robert A Gibson; Andrew J Sinclair; Maria Makrides; Kerin O'Dea; Dallas R English; Graham G Giles Journal: Nutr Metab Cardiovasc Dis Date: 2006-09-07 Impact factor: 4.222
Authors: Liana C Del Gobbo; Fumiaki Imamura; Stella Aslibekyan; Matti Marklund; Jyrki K Virtanen; Maria Wennberg; Mohammad Y Yakoob; Stephanie E Chiuve; Luicito Dela Cruz; Alexis C Frazier-Wood; Amanda M Fretts; Eliseo Guallar; Chisa Matsumoto; Kiesha Prem; Tosh Tanaka; Jason H Y Wu; Xia Zhou; Catherine Helmer; Erik Ingelsson; Jian-Min Yuan; Pascale Barberger-Gateau; Hannia Campos; Paulo H M Chaves; Luc Djoussé; Graham G Giles; Jose Gómez-Aracena; Allison M Hodge; Frank B Hu; Jan-Håkan Jansson; Ingegerd Johansson; Kay-Tee Khaw; Woon-Puay Koh; Rozenn N Lemaitre; Lars Lind; Robert N Luben; Eric B Rimm; Ulf Risérus; Cecilia Samieri; Paul W Franks; David S Siscovick; Meir Stampfer; Lyn M Steffen; Brian T Steffen; Michael Y Tsai; Rob M van Dam; Sari Voutilainen; Walter C Willett; Mark Woodward; Dariush Mozaffarian Journal: JAMA Intern Med Date: 2016-08-01 Impact factor: 21.873
Authors: Mieke Cabout; Marjan Alssema; Giel Nijpels; Coen D A Stehouwer; Peter L Zock; Ingeborg A Brouwer; Amany K Elshorbagy; Helga Refsum; Jacqueline M Dekker Journal: Eur J Nutr Date: 2016-07-14 Impact factor: 5.614
Authors: Zayed D Alsharari; Ulf Risérus; Karin Leander; Per Sjögren; Axel C Carlsson; Max Vikström; Federica Laguzzi; Bruna Gigante; Tommy Cederholm; Ulf De Faire; Mai-Lis Hellénius; Matti Marklund Journal: PLoS One Date: 2017-01-26 Impact factor: 3.240
Authors: Kamalita Pertiwi; Anne J Wanders; Marjolein C Harbers; Leanne K Küpers; Sabita S Soedamah-Muthu; Janette de Goede; Peter L Zock; Johanna M Geleijnse Journal: Diabetes Care Date: 2019-11-14 Impact factor: 19.112
Authors: Frank Qian; Andres V Ardisson Korat; Fumiaki Imamura; Matti Marklund; Nathan Tintle; Jyrki K Virtanen; Xia Zhou; Julie K Bassett; Heidi Lai; Yoichiro Hirakawa; Kuo-Liong Chien; Alexis C Wood; Maria Lankinen; Rachel A Murphy; Cecilia Samieri; Kamalita Pertiwi; Vanessa D de Mello; Weihua Guan; Nita G Forouhi; Nick Wareham; InterAct Consortium Frank B Hu; Ulf Riserus; Lars Lind; William S Harris; Aladdin H Shadyab; Jennifer G Robinson; Lyn M Steffen; Allison Hodge; Graham G Giles; Toshiharu Ninomiya; Matti Uusitupa; Jaakko Tuomilehto; Jaana Lindström; Markku Laakso; David S Siscovick; Catherine Helmer; Johanna M Geleijnse; Jason H Y Wu; Amanda Fretts; Rozenn N Lemaitre; Renata Micha; Dariush Mozaffarian; Qi Sun Journal: Diabetes Care Date: 2021-03-03 Impact factor: 19.112
Authors: Tonje Skarpengland; Magnhild E Macpherson; Johannes R Hov; Xiang Y Kong; Pavol Bohov; Bente Halvorsen; Børre Fevang; Rolf K Berge; Pål Aukrust; Silje F Jørgensen Journal: J Clin Immunol Date: 2021-10-20 Impact factor: 8.317
Authors: Kamalita Pertiwi; Leanne K Küpers; Janette de Goede; Peter L Zock; Daan Kromhout; Johanna M Geleijnse Journal: J Am Heart Assoc Date: 2021-11-30 Impact factor: 6.106
Authors: Annick P M van Soest; Ondine van de Rest; Renger F Witkamp; Tommy Cederholm; Lisette C P G M de Groot Journal: Eur J Nutr Date: 2022-06-15 Impact factor: 4.865
Authors: Kamalita Pertiwi; Leanne K Küpers; Johanna M Geleijnse; Peter L Zock; Anne J Wanders; Herculina S Kruger; Tertia van Zyl; Iolanthé M Kruger; Cornelius M Smuts Journal: Lipids Health Dis Date: 2020-06-16 Impact factor: 3.876
Authors: Kamalita Pertiwi; Leanne K Küpers; Anne J Wanders; Janette de Goede; Peter L Zock; Johanna M Geleijnse Journal: Nutr Metab (Lond) Date: 2019-11-13 Impact factor: 4.169